Ruggeri, M., Basile, M., Armuzzi, A., & Cicchetti, A. (2017). Activity-based costing and budget analysis of vedolizumab versus conventional treatments in ulcerative colitis and Crohn’s disease: Analisi Organizzativa e di Budget Dell’introduzione di Vedolizumab Vs Terapie Tradizionali in Colite Ulcerosa e Morbo di Crohn. Global and Regional Health Technology Assessment, 4(1), 88–99. https://doi.org/10.33393/grhta.2017.382